Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 20347-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#20347-1-AP, RRID:AB_10693616
- Product name
- FGD3 antibody
- Antibody type
- Polyclonal
- Description
- FGD3 antibody (Cat. #20347-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references FGD3 mediates lytic cell death, enhancing efficacy and immunogenicity of chemotherapy agents in breast cancer.
Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy synergy between CARM1 inhibition and IMiDs.
FGD3 binds with HSF4 to suppress p65 expression and inhibit pancreatic cancer progression.
Zhu J, Dai X, Ghosh S, Wei E, Mao C, Jiang Q, Spaulding AJ, Mulligan MP, Romero R, Han YJ, Boudreau MW, Olopade O, Hergenrother PJ, Shapiro DJ
Journal of experimental & clinical cancer research : CR 2025 Nov 13;44(1):299
Journal of experimental & clinical cancer research : CR 2025 Nov 13;44(1):299
Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy synergy between CARM1 inhibition and IMiDs.
Ni W, Garg S, Chowdhury B, Sattler M, Sanchez D, Meng C, Akatsu T, Donovan KA, Qi J, Wang MY, Starnbach CA, Liu X, Guzman MT, Teh WP, Stone R, Griffin JD, Buhrlage S, Weisberg E
Molecular therapy. Oncology 2025 Mar 20;33(1):200952
Molecular therapy. Oncology 2025 Mar 20;33(1):200952
FGD3 binds with HSF4 to suppress p65 expression and inhibit pancreatic cancer progression.
Guo F, Cheng X, Jing B, Wu H, Jin X
Oncogene 2022 Feb;41(6):838-851
Oncogene 2022 Feb;41(6):838-851
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- A431 cells were subjected to SDS PAGE followed by western blot with 20347-1-AP(FGD3 antibody) at dilution of 1:500
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunofluorescent analysis of Hela cells, using FGD3 antibody 20347-1-AP at 1:25 dilution and Rhodamine-labeled goat anti-rabbit IgG (red).
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human placenta using 20347-1-AP(FGD3 antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human placenta using 20347-1-AP(FGD3 antibody) at dilution of 1:50 (under 40x lens)
- Sample type
- tissue
